Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cazanave

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Scientific Reports|September 16, 2023
Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective studyM Lahouati, C Cazanave, A Labadie, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|March 19, 2019
[Pelvic Inflammatory Diseases: Updated Guidelines for Clinical Practice - Short version]J-L Brun, B Castan, B de Barbeyrac, et al.
Journal of Hepatology|December 15, 2010
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosisSamar H Ibrahim, Yuko Akazawa, Sophie C Cazanave, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 15, 2011
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosisKeisuke Kakisaka, Sophie C Cazanave, Christian D Fingas, et al.
Hepatology (Baltimore, Md.)|April 23, 2014
Saturated free fatty acids induce cholangiocyte lipoapoptosisSathish Kumar Natarajan, Sally A Ingham, Ashley M Mohr, et al.
Infectious Diseases Now|October 23, 2020
Severe adverse events during medical and surgical treatment of hip and knee prosthetic joint infectionsS Perez, F-A Dauchy, F Salvo, et al.
Journal of Hepatology|April 21, 2009
Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivoJin-Ping Lai, Dalbir S Sandhu, Catherine D Moser, et al.
BMC Infectious Diseases|November 17, 2020
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohortF Bonnet, F Le Marec, O Leleux, et al.
Plos One|April 13, 2011
Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cellsSatoshi Kurita, Justin L Mott, Sophie C Cazanave, et al.
Hepatology (Baltimore, Md.)|November 1, 2011
Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cellsChristian D Fingas, Steven F Bronk, Nathan W Werneburg, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Scientific Reports|September 16, 2023
Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective studyM Lahouati, C Cazanave, A Labadie, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|March 19, 2019
[Pelvic Inflammatory Diseases: Updated Guidelines for Clinical Practice - Short version]J-L Brun, B Castan, B de Barbeyrac, et al.
Journal of Hepatology|December 15, 2010
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosisSamar H Ibrahim, Yuko Akazawa, Sophie C Cazanave, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 15, 2011
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosisKeisuke Kakisaka, Sophie C Cazanave, Christian D Fingas, et al.
Hepatology (Baltimore, Md.)|April 23, 2014
Saturated free fatty acids induce cholangiocyte lipoapoptosisSathish Kumar Natarajan, Sally A Ingham, Ashley M Mohr, et al.
Infectious Diseases Now|October 23, 2020
Severe adverse events during medical and surgical treatment of hip and knee prosthetic joint infectionsS Perez, F-A Dauchy, F Salvo, et al.
Journal of Hepatology|April 21, 2009
Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivoJin-Ping Lai, Dalbir S Sandhu, Catherine D Moser, et al.
BMC Infectious Diseases|November 17, 2020
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohortF Bonnet, F Le Marec, O Leleux, et al.
Plos One|April 13, 2011
Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cellsSatoshi Kurita, Justin L Mott, Sophie C Cazanave, et al.
Hepatology (Baltimore, Md.)|November 1, 2011
Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cellsChristian D Fingas, Steven F Bronk, Nathan W Werneburg, et al.
Pageof 6